All Posts

Ceryx Medical has taken a significant step in strengthening its leadership team by appointing Mark Strong as a Non-Executive Director. This move signals the company’s commitment to advancing its position in the medtech sector, particularly in the cardiac rhythm management (CRM) space. Mark Strong brings decades of experience from leading medical technology companies, including Abbott and Boston Scientific, which positions him well to guide Ceryx Medical through its next phase

We’ve just secured $15 million in new funding to accelerate the development of our next-generation, biomimetic pacemaker—designed to work...

Professor Julian Paton, Director of the Centre for Heart Research – Manaaki Manawa, University of Auckland and co-Director of Pūtahi...